Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications
Summary
Nanoparticle-based phototherapy represents a paradigm shift in precision medicine, harnessing light-activated mechanisms to modulate cellular pathways across a spectrum of diseases. By integrating nanoparticles, phototherapeutic modalities achieve enhanced light absorption and improved targeting and amplification effects, such as reactive oxygen species generation in photodynamic therapy and localized heating in photothermal therapy. Gold nanoparticles and hybrid constructs have attracted
Content
# Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications
*Published: 2026 Mar 16*
Nanoparticle-based phototherapy represents a paradigm shift in precision
medicine, harnessing light-activated mechanisms to modulate cellular pathways
across a spectrum of diseases. By integrating nanoparticles, phototherapeutic
modalities achieve enhanced light absorption and improved targeting and
amplification effects, such as reactive oxygen species generation in
photodynamic therapy and localized heating in photothermal therapy. Gold
nanoparticles and hybrid constructs have attracted considerable attention in
both photothermal and photodynamic therapies, while delivery platforms, such as
liposomes and dendrimers, fine-tune biodistribution and release kinetics. At the
molecular level, phototherapy induces oxidative stress, triggers apoptotic and
autophagic cascades and modulates immune responses by altering cytokine profiles
and T-cell activity processes, which are critical not only in cancer therapy but
also in managing various chronic conditions, including cardiovascular,
neurodegenerative, metabolic and autoimmune disorders. In this review, we chart
the evolution of nanoparticle-based phototherapy systems by examining their core
components, classification schemes and delivery platforms that drive treatment
specificity. We then dissect the underlying signaling pathways, highlighting how
light-triggered interventions intersect with key molecular networks in chronic
disease contexts. Additionally, we critically evaluate FDA-approved agents and
insights from recent clinical trials, outlining the major challenges to clinical
translation, including nanoparticle optimization, efficient light delivery and
regulatory hurdles. By integrating molecular insights with clinical
advancements, nanoparticle-based phototherapy has emerged as a transformative,
noninvasive strategy poised to revolutionize therapeutic approaches for a wide
range of diseases.
DOI: 10.1038/s41392-025-02536-w